Latest literature

1. Boldt J. Volume therapy in cardiac surgery: are Americans different from Europeans? J Cardiothorac Vasc Anesth 2006;20:98-105. [Abstract]
   
   
2. Sato K, Namura O, Sogawa M, Shimada K, Tosaka Y, Hayashi J. A reduced priming system. Artif Organs 2006;30:635-8. [Abstract]
   
   
3. Rex S, Scholz M, Weyland A, Busch T, Schorn B, Buhre W. Intra- and extravascular volume status in patients undergoing mitral valve replacement: crystalloid vs. colloid priming of cardiopulmonary bypass. Eur J Anaesthesiol 2006;23:1-9. [Abstract]
   
   
4. Chong Sung K, Kum Suk P, Mi Ja Y, Kyoung Ok K. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Acta Anaesthesiol Scand 2006;50:108-1.[Abstract]
   
   
5. Sobieski MA 2nd, Slaughter MS, Hart DE, Pappas PS, Tatooles AJ. Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use. Perfusion 2005;20:31-7. [Abstract]
   
   
6. Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, De Paep R, Rodrigus I, Daper A, Trenchant A. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 2005;101:629-34. [Abstract]